Teva spent $2.2 million on lobbying in the US.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) spent $2.2 million on lobbying in the US in 2008, 90% more than in 2007. The company spent $510,000 on lobbying in the fourth quarter of 2008 alone. The US government is about to issue new rules for biogenerics.
In the US, Teva lobbies the Senate and House of Representatives, the Food and Drug Administration (FDA), and other federal agencies. The company lobbies for a range of issues, including biogenerics, drug imports, drug patents and commercialization, and efforts against drug forgery.
Published by Globes [online], Israel business news - www.globes-online.com - on January 25, 2009
© Copyright of Globes Publisher Itonut (1983) Ltd. 2009